FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS
The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihydro-l-[(4-methylphenyl)methyl]-5-oxo- lH-l,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- comprisi...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihydro-l-[(4-methylphenyl)methyl]-5-oxo- lH-l,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- comprising 75 µg or less of Propanoic Acid, 2-[4-[3-[2,5-dihydro-l-[(4-methylphenyl)methyl]-5-oxo-lH-l,2,4-triazol-3- yl]propyl]phenoxy]-2-methyl- per dosage unit.
Régimes de dosage pour agonistes de PPAR-alpha et compositions correspondantes. Selon une variante, on décrit une formulation orale solide d'acide propanoïque, 2-[4-[3-[2,5-dihydro-l-[(4-méthylphényl)méthyl]-5-oxo- lH-l,2,4-triazol-3-yl]propyl]phénoxy]-2-méthyl- comprenant 75 ?g, ou moins, d'acide propanoïque, 2-[4-[3-[2,5-dihydro-l-[(4-méthylphényl)méthyl]-5-oxo-lH-l,2,4-triazol-3- yl]propyl]phénoxy]-2-méthyl- par unité de dosage. |
---|